CD57 is a marker of terminally differentiated, non-proliferative T cells (senescence and exhaustion) and the frequency of CD57+CD4+ and CD57+CD8+ T cells increases with age as well as with cancer and chronic infections (60). This evidence concerns the gene CD4 and cancer.